Triclabendazole Production Cost Reports

The report provides a detailed analysis essential for establishing a Triclabendazole production plant. It encompasses all critical aspects necessary for Triclabendazole production, including the cost of Triclabendazole production, Triclabendazole plant cost, Triclabendazole production costs, and the overall Triclabendazole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Triclabendazole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Triclabendazole is an anthelmintic medication that is used to treat fascioliasis, which is a parasitic infection caused by liver flukes like Fasciola hepatica and Fasciola gigantica. This infection affects the liver and bile ducts after ingestion of contaminated water plants, like watercress or undercooked animals.

It works by disrupting the parasites' microtubule function, which stops glucose uptake and leads to their death. It is effective against both immature and adult flukes, which makes it the preferred choice for all stages of the disease in patients aged 6 years and older. It is also utilised for the treatment of paragonimiasis (lung fluke infection) and in veterinary medicine for livestock parasites. It is administered orally in two doses 12 hours apart, and has common side effects like abdominal pain, diarrhoea, nausea, vomiting, headache, dizziness, increased sweating, loss of appetite, and fever.

The Triclabendazole market is driven by the rising cases of parasitic infections like fascioliasis in livestock and humans. Its utilisation in treating liver fluke diseases affecting agriculture in endemic regions contributes to its market growth. The expanding global livestock sector, with a focus on animal health, advanced veterinary healthcare systems, and increasing awareness among farmers, boosts its market. The North American region leads its market because of high livestock production and innovation, while the Asia-Pacific region shows fast expansion due to demand for animal products.

The industrial Triclabendazole procurement is influenced by regulatory standards for safe use in veterinary and human applications. Also, regional variations in government policies supporting disease control, competition from generics post-patent dynamics, and raw material availability further affect its sourcing strategies.

Raw Material for Triclabendazole Production

According to the Triclabendazole production plant project report, the key raw materials used in the production of Triclabendazole include (5-Chloro-6-(2,3-Dichlorophenoxy)-1H-Benzimidazol-2(3H)-Thione)-Potassium Hydroxide-Iodomethane.

Production Process of Triclabendazole

The extensive Triclabendazole production cost report consists of the following major industrial production process:

1. By Methylation: The synthesis of Triclabendazole involves methylation of 5-chloro-6-(2,3-dichlorophenoxy)-1H-benzimidazol-2(3H)-thione in an ethanol-water solution containing potassium hydroxide. To this mixture, Iodomethane is added dropwise at 10–15  degree Celsius, the reaction is stirred at room temperature and then heated to 50  degree Celsius. The resulting emulsion is poured into water to get a precipitate that is filtered, washed, and dried to give Triclabendazole as the final product.

Triclabendazole is a white to beige or light yellow crystalline solid. It has a molecular formula of C14H9Cl3N2OS and a molecular weight of 359.65-359.66 g/mol. It has a melting point of 175-177 degree Celsius and is almost insoluble in water. It is soluble in DMSO, ethanol, acetonitrile, and methanol and has a density of around 1.39 g/cm³. It has a refractive index of around 1.60 and a predicted pKa of 7.91. It is chemically stable when stored sealed at room temperature or -20 degree Celsius. It has a benzimidazole structure with rapid tautomerism and shows low volatility with a boiling point of 240.6 degree Celsius. All these properties make it useful in oral formulations for treating fascioliasis.